Fitus Brand Ranking

FITUS

Shanghai Renhui Biopharmaceutical Co., Ltd.

Industry： drug , Weight loss pills

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

FITUS

Shanghai Renhui Biopharmaceutical Co., Ltd.

Industry： drug , Weight loss pills

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

Brand Introduction

FITUS benaglutide injection, combined with diet control and exercise, is used for weight management in adults.

Renhui Bio is an innovative biopharmaceutical company founded in 1999, focusing on the research, development and commercialization of innovative biopharmaceuticals in the field of chronic diseases. After more than 20 years of dedicated exploration, Renhui Bio has gained innovative drug results in the fields of diabetes and weight loss, and has laid a wealth of R&D pipelines in the fields of endocrine and cardiovascular diseases.

Since its establishment, the company has successively signed scientific research projects such as the "Eleventh Five-Year Plan" and "13th Five-Year Plan" major new drug creation projects, major projects for strategic emerging industries in Shanghai, and major scientific and technological research projects in Shanghai. In the field of diabetes, the innovative biological drug benaglutide injection was independently developed. In the field of weight loss, the full-human GLP-1 receptor agonist Feisumei® was approved in July 2023.

Renhui Bio takes continuous innovation as the cornerstone of its development and has built multiple core technology platforms in drug discovery, CMC, clinical research, etc. In the field of genetic engineering tandem technology, the company's technical patents have been authorized by more than a dozen countries including the United States, Europe, Japan, and the middle school. Based on this, the company has formed solid technical accumulation in all process links of polypeptide and protein drug preparation technology. . At present, the company has applied for 30 invention patents in China and obtained 18 authorizations; applied for 105 international invention patents, and obtained 61 authorizations.

Renhui Bio's Shanghai Production Base was completed in 2009 and the expansion project was approved in 2019. It has a world-class customized system and equipment, fully automated regulation of the production process, and the data can be traced throughout the process. With advanced quality management concepts, we penetrate into every link of daily management, and strive for excellence for every patient.

Patients are the first and science is the basis. Renhui Bio's vision is to become a more clinically valuable enterprise in the field of innovative drugs, and to serve the desire of chronic disease patients for life and health with enthusiasm.

Related Keywords: FITUS drug , FITUS Weight loss pills